What companies are SYNB's competitors?

Putnam BioRevolution ETF (SYNB)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does SYNB compare to its peers?

The peer comparison table on this page shows Putnam BioRevolution ETF (SYNB) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does SYNB operate in?

Putnam BioRevolution ETF (SYNB) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

SYNB (Putnam BioRevolution ETF) is no longer actively trading.

This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

SYNB

Putnam BioRevolution ETF

AMEX·Asset Management · Financial Services

$31.61$0.12−0.37%

Market cap$5.29M·Market closed·Nov 13 9:00 PM UTC

Frequently Asked Questions About SYNB

What companies are SYNB's competitors?: Putnam BioRevolution ETF (SYNB)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does SYNB compare to its peers?: The peer comparison table on this page shows Putnam BioRevolution ETF (SYNB) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does SYNB operate in?: Putnam BioRevolution ETF (SYNB) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

SYNB (Putnam BioRevolution ETF) is no longer actively trading.

SYNB

Putnam BioRevolution ETF

AMEX·Asset Management · Financial Services

$31.61$0.12−0.37%

Market cap$5.29M·Market closed·Nov 13 9:00 PM UTC

Peers


IPOS	Renaissance International IPO ETF	$22.89	$6.8M
UPGR	Xtrackers US Green Infrastructure Select Equity ETF	$25.16	$5.7M
EXUS	Macquarie Focused International Core ETF	$27.79	$5.6M
SEPI	Shelton Equity Premium Income ETF	$28.08	$5.6M
FRIZ	Franklin Dividend Growth ETF	$26.64	$5.3M
RVRB	Reverb ETF	$33.49	$5.3M
AWEG	Alger Weatherbie Enduring Growth ETF	$22.55	$5.2M
SPCZ	RiverNorth Enhanced Pre-Merger SPAC ETF	$26.06	$5.0M
BWEB	Bitwise Web3 ETF	$74.90	$4.6M
ODDS	Pacer BlueStar Digital Entertainment ETF	$23.90	$3.7M

Frequently Asked Questions About SYNB

What companies are SYNB's competitors?: Putnam BioRevolution ETF (SYNB)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does SYNB compare to its peers?: The peer comparison table on this page shows Putnam BioRevolution ETF (SYNB) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does SYNB operate in?: Putnam BioRevolution ETF (SYNB) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.